Skip to main content

Advertisement

Table 1 Demographic features and clinical characteristics of TS patients and healthy controls

From: Altered monocyte activation markers in Tourette’s syndrome: a case–control study

  n TS patients n Healthy controls
Age, mean ± SD (range) 46 29.3 ± 14.1 (8–62) 43 30.6 ± 13.8 (8–62)
< 18 years, n (%) 15 33% 10 23%
Age of onset, mean ± SD (range) 46 8.2 ± 3.7 (2–17) 43 n.a.
Male:female ratio (n) 46 3.6:1 (36 m, 10 f) 43 2.3:1 (30 m, 13 f)
TSGS values, mean ± SD (range) 46 40.2 ± 13.0 (16.8 - 64.3) 43 n.a.
OCD, n (%), MOCI ≥12, mean ± SD (range) 34 74% 13.1 ± 2.8 (12–26) 0 0%
No OCD n (%), MOCI < 12 mean ± SD (range) 12 26% 0.42 ± 0.79 (0–2) 43 100% 1.42 ± 0.96 (0–4)
Psychotropic medication1, n (%) 30 65% 0 0%
Not medicated 16 35% 43 100%
  1. TS = Tourette’s syndrome, OCD = obsessive compulsive disorder, MOCI = Maudsley Obsessive-Compulsive Inventory, TSGS = Tourette’s Syndrome Global Scale, n = number, f = female, m = male, SD = standard deviation, n.a. = not applicable.
  2. 1including neuroleptics (n = 18), tiapride (n = 11) and antidepressants (n = 7).